Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hui Wu, Yuanyuan Bao, Xiang Wang, Dongming Zhou & Wenzhe Wu. (2017) Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines. Human Vaccines & Immunotherapeutics 13:6, pages 1279-1287.
Read now
Read now
Jasmine Tomar, Philip A. Born, Henderik W. Frijlink & Wouter L. J. Hinrichs. (2016) Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination. Expert Review of Vaccines 15:11, pages 1431-1447.
Read now
Read now
Fang He, Sonja Leyrer & Jimmy Kwang. (2016) Strategies towards universal pandemic influenza vaccines. Expert Review of Vaccines 15:2, pages 215-225.
Read now
Read now
Patricia Kaaijk, Deborah E Kleijne, Mirjam J Knol, Irene A Harmsen, Olga JAE Ophorst & Nynke Y Rots. (2014) Parents’ attitude toward multiple vaccinations at a single visit with alternative delivery methods. Human Vaccines & Immunotherapeutics 10:8, pages 2483-2489.
Read now
Read now
Markus A Rose. (2014) Mucosal immunization in perspective. Human Vaccines & Immunotherapeutics 10:7, pages 2115-2117.
Read now
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now
Read now
Articles from other publishers (62)
Caruso Arturo Armone, Miglietta Anna, De Rossi Giovanni, Nappi Liliana, Viola Veronica, De Rossi Stefano, Del Prete Salvatore, Imperatore Clara, Leo Sabato, Naviglio Daniele, Gallo Monica, Marasco Daniela & Grumetto Lucia. (2023) Nasal cytology in patients with previous SARS-CoV-2 infection: occurrence of atypical lymphocytes. Advanced Treatments in ENT Disorders 7:1, pages 001-006.
Crossref
Crossref
Bin Tu, Yanrong Gao, Xinran An, Huiyuan Wang & Yongzhuo Huang. (2023) Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharmaceutica Sinica B 13:5, pages 1828-1846.
Crossref
Crossref
Maria Victoria Sanchez, Thomas Ebensen, Kai Schulze, Diego Esteban Cargnelutti, Eduardo A. Scodeller & Carlos A. Guzmán. (2023) Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG. Pharmaceutics 15:3, pages 912.
Crossref
Crossref
Polina Prokopenko, Victoria Matyushenko, Alexandra Rak, Ekaterina Stepanova, Anna Chistyakova, Arina Goshina, Igor Kudryavtsev, Larisa Rudenko & Irina Isakova-Sivak. (2023) Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein. Vaccines 11:3, pages 501.
Crossref
Crossref
Fengcai Zhu, Chunlan Zhuang, Kai Chu, Liang Zhang, Hui Zhao, Shoujie Huang, Yingying Su, Hongyan Lin, Changlin Yang, Hanmin Jiang, Xia Zang, Donglin Liu, Hongxing Pan, Yuemei Hu, Xiaohui Liu, Qi Chen, Qiaoqiao Song, Jiali Quan, Zehong Huang, Guohua Zhong, Junyu Chen, Jinle Han, Hong Sun, Lunbiao Cui, Jingxin Li, Yixin Chen, Tianying Zhang, Xiangzhong Ye, Changgui Li, Ting Wu, Jun Zhang & Ning-Shao Xia. (2022) Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials. The Lancet Respiratory Medicine 10:8, pages 749-760.
Crossref
Crossref
Chunhong Dong, Ye Wang, Wandi Zhu, Yao Ma, Joo Kim, Lai Wei, Gilbert X. Gonzalez & Bao-Zhong Wang. (2022) Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice. ACS Applied Materials & Interfaces 14:5, pages 6331-6342.
Crossref
Crossref
Mattia Tiboni, Luca Casettari & Lisbeth Illum. (2021) Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?. International Journal of Pharmaceutics 603, pages 120686.
Crossref
Crossref
Chunhong Dong, Ye WangGilbert X. GonzalezYao MaYufeng SongShelly Wang, Sang-Moo KangRichard W. Compans & Bao-Zhong Wang. (2021) Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains. Proceedings of the National Academy of Sciences 118:19.
Crossref
Crossref
Sedigheh Taghinezhad-S, Amir Hossein Mohseni, Luis G. Bermúdez-Humarán, Vincenzo Casolaro, Naima G. Cortes-Perez, Hossein Keyvani & Jesus Simal-Gandara. (2021) Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease. Vaccines 9:5, pages 466.
Crossref
Crossref
Oreste Gallo, Luca Giovanni Locatello, Alessio Mazzoni, Luca Novelli & Francesco Annunziato. (2021) The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Mucosal Immunology 14:2, pages 305-316.
Crossref
Crossref
Tao Qin, Shang Ma, Xinyu Miao, Yan Tang, Dandan Huangfu, Jinyuan Wang, Jing Jiang, Nuo Xu, Yuncong Yin, Sujuan Chen, Xiufan Liu, Yinyan Yin, Daxin Peng & Lizeng Gao. (2020) Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant. Advanced Science 7:18, pages 2000771.
Crossref
Crossref
Yohei Takeda, Yuko Okuyama, Hiroto Nakano, Yasunori Yaoita, Koich Machida, Haruko Ogawa & Kunitoshi Imai. (2019) Antiviral Activities of Hibiscus sabdariffa L. Tea Extract Against Human Influenza A Virus Rely Largely on Acidic pH but Partially on a Low-pH-Independent Mechanism. Food and Environmental Virology 12:1, pages 9-19.
Crossref
Crossref
Xiangpeng Chen, Yong Zhang, Naiying Mao, Shuangli Zhu, Tianjiao Ji & Wenbo Xu. (2019) Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice. Archives of Virology 164:12, pages 2975-2984.
Crossref
Crossref
Tamiru N. Alkie, Jondavid de Jong, Kristof Jenik, Karl M. Klinger & Stephanie J. DeWitte-Orr. (2019) Enhancing innate antiviral immune responses in rainbow trout by double stranded RNA delivered with cationic phytoglycogen nanoparticles. Scientific Reports 9:1.
Crossref
Crossref
Jann Catherine Ang, Biao Wang, Joanne J.F. Wang, Peter Yu Fan Zeng, Florian Krammer, Brian J. Ward, Margaret L. Russell, Mark Loeb & Matthew S. Miller. (2019) Comparative Immunogenicity of the 2014–2015 Northern Hemisphere Trivalent IIV and LAIV against Influenza A Viruses in Children. Vaccines 7:3, pages 87.
Crossref
Crossref
Su He Wang, Douglas Smith, Zhengyi Cao, Jesse Chen, Hugo Acosta, Jessica A. Chichester, Vidadi Yusibov, Stephen J. Streatfield, Ali Fattom & James R. BakerJrJr. (2019) Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge. Vaccine 37:12, pages 1591-1600.
Crossref
Crossref
Daiju Sakurai, Ryosuke Uchida, Fumie Ihara, Naoki Kunii, Takuya Nakagawa, Hideaki Chazono, Toyoyuki Hanazawa, Shinichiro Motohashi & Yoshitaka Okamoto. (2018) Immunosuppressive property of submandibular lymph nodes in patients with head and neck tumors: differential distribution of regulatory T cells. BMC Research Notes 11:1.
Crossref
Crossref
Tamiru Negash Alkie, Alexander Yitbarek, Khaled Taha-Abdelaziz, Jake Astill & Shayan Sharif. (2018) Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens. PLOS ONE 13:11, pages e0206324.
Crossref
Crossref
Holly R. Hughes, Susan L. Brockmeier & Crystal L. Loving. (2018) Bordetella bronchiseptica Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge. Frontiers in Immunology 9.
Crossref
Crossref
Valentina Bernasconi, Beatrice Bernocchi, Liang Ye, Minh Quan Lê, Ajibola Omokanye, Rodolphe Carpentier, Karin Schön, Xavier Saelens, Peter Staeheli, Didier Betbeder & Nils Lycke. (2018) Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections. Frontiers in Immunology 9.
Crossref
Crossref
Youhui Si, Yi Wen, Sean H. Kelly, Anita S. Chong & Joel H. Collier. (2018) Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses. Journal of Controlled Release 282, pages 120-130.
Crossref
Crossref
D G Eliasson, A Omokanye, K Schön, U A Wenzel, V Bernasconi, M Bemark, A Kolpe, K El Bakkouri, T Ysenbaert, L Deng, W Fiers, X Saelens & N Lycke. (2018) M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection. Mucosal Immunology 11:1, pages 273-289.
Crossref
Crossref
Nitin Machindra Kamble, Kim Je Hyoung & John Hwa Lee. (2017) Intracellular delivery of HA1 subunit antigen through attenuated Salmonella Gallinarum act as a bivalent vaccine against fowl typhoid and low pathogenic H5N3 virus. Veterinary Research 48:1.
Crossref
Crossref
Chenguang Shen, Junyu ChenRui LiMengya ZhangGuosong WangSvetlana StegalkinaLimin ZhangJing ChenJianli Cao, Xingjian BiStephen F. Anderson, Timothy Alefantis, Minwei ZhangXiaoyang CaiKunyu YangQingbing ZhengMujing FangHai Yu, Wenxin LuoZizheng ZhengQuan YuanJun ZhangJames Wai-Kuo ShihHarry KleanthousHonglin Chen, Yixin Chen & Ningshao Xia. (2017) A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses. Science Translational Medicine 9:412.
Crossref
Crossref
G. D. Petukhova, I. V. Losev, I. N. Isakova-Sivak & L. G. Rudenko. (2018) Influence of Individual Mutations in Genes Coding Internal Proteins of the Influenza A Virus on Formation of Humoral and Cellular Immune Response in Mice. Molecular Genetics, Microbiology and Virology 32:3, pages 160-167.
Crossref
Crossref
Akira AinaiTadaki SuzukiShin-ichi TamuraHideki Hasegawa. (2017) Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate. Viral Immunology 30:6, pages 451-462.
Crossref
Crossref
Weiping Cao, Jin Hyang Kim, Adrian J. Reber, Mary Hoelscher, Jessica A. Belser, Xiuhua Lu, Jacqueline M. Katz, Shivaprakash Gangappa, Martin Plante, David S. Burt & Suryaprakash Sambhara. (2017) Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice. Vaccine 35:25, pages 3318-3325.
Crossref
Crossref
Shu-Ting Ren, Xue-Mei Zhang, Peng-Fei Sun, Li-Juan Sun, Xue Guo, Tian Tian, Jian Zhang, Qi-Yuan Guo, Xue Li, Li-Jun Guo, Jin Che, Bing Wang & Hui Zhang. (2017) Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59. PLOS ONE 12:1, pages e0169501.
Crossref
Crossref
G. D. Petukhova, I. V. Losev, I. N. Isakova-Sivak & L. G. Rudenko. (2017) Effect of single mutations in the internal protein genes of Influenza A virus on the antibody and cellular immune responses in mice. Molecular Genetics Microbiology and Virology (Russian version) 35:3, pages 108.
Crossref
Crossref
P. Holla, M.A. Baikoghli, P. Soonsawad & R.H. Cheng. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
303
326
.
Rob Lambkin-Williams, Colin Gelder, Richard Broughton, Corey P. Mallett, Anthony S. Gilbert, Alex Mann, David He, John S. Oxford & David Burt. (2016) An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection. PLOS ONE 11:12, pages e0163089.
Crossref
Crossref
C. Chiu. (2016) Seasonal influenza vaccines and hurdles to mutual protection. Clinical Microbiology and Infection 22, pages S113-S119.
Crossref
Crossref
Constantina Boikos, Lawrence Joseph, Christine Martineau, Jesse Papenburg, David Scheifele, Larry C. Lands, Gaston De Serres, Mark Chilvers & Caroline Quach. (2016) Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings. Open Forum Infectious Diseases 3:4.
Crossref
Crossref
Teena Mohan, Jongrok Kim, Zachary Berman, Shelly Wang, Richard W. Compans & Bao-Zhong Wang. (2016) Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses. Journal of Controlled Release 233, pages 208-219.
Crossref
Crossref
Shinji Saito, Akira Ainai, Tadaki Suzuki, Norihiro Harada, Yasushi Ami, Yoshikazu Yuki, Haruko Takeyama, Hiroshi Kiyono, Hideo Tsukada & Hideki Hasegawa. (2016) The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine. Vaccine 34:9, pages 1201-1207.
Crossref
Crossref
Shin-ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata & Hideki Hasegawa. (2016) Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?. Japanese Journal of Infectious Diseases 69:3, pages 165-179.
Crossref
Crossref
Kai Schulze, Thomas Ebensen, Peggy Riese, Blair Prochnow, Claus-Michael Lehr & Carlos A. Guzmán. 2016. How to Overcome the Antibiotic Crisis. How to Overcome the Antibiotic Crisis
207
234
.
Hyun Jong Noh, Mohammed Y. E. Chowdhury, Seonghun Cho, Jae-Hoon Kim, Hye Sun Park, Chul-Joong Kim, Haryoung Poo, Moon-Hee Sung, Jong-Soo Lee & Yong Taik Lim. (2015) Programming of Influenza Vaccine Broadness and Persistence by Mucoadhesive Polymer-Based Adjuvant Systems. The Journal of Immunology 195:5, pages 2472-2482.
Crossref
Crossref
Rui Li, Mohammed Y.E. Chowdhury, Jae-Hoon Kim, Tae-Hwan Kim, Prabuddha Pathinayake, Wan-Seo Koo, Min-Eun Park, Ji-Eun Yoon, Jong-Bok Roh, Seung-Pyo Hong, Moon-Hee Sung, Jong-Soo Lee & Chul-Joong Kim. (2015) Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes. Veterinary Microbiology 179:3-4, pages 250-263.
Crossref
Crossref
Reinhard Pabst. (2015) Mucosal vaccination by the intranasal route. Nose-associated lymphoid tissue (NALT)—Structure, function and species differences. Vaccine 33:36, pages 4406-4413.
Crossref
Crossref
Y Yin, T Qin, X Wang, J Lin, Q Yu & Q Yang. (2015) CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunology 8:4, pages 799-814.
Crossref
Crossref
Shujing Wang, Huiqin Liu, Xinyi Zhang & Feng Qian. (2015) Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies. Protein & Cell 6:7, pages 480-503.
Crossref
Crossref
Francesca Ferrara, Eleonora Molesti & Nigel Temperton. (2015) The application of pseudotypes to influenza pandemic preparedness. Future Virology 10:6, pages 731-749.
Crossref
Crossref
Tao Qin, Yinyan Yin, Qinghua Yu, Lulu Huang, Xiaoqing Wang, Jian Lin & Qian Yang. (2015) CpG Oligodeoxynucleotides Facilitate Delivery of Whole Inactivated H9N2 Influenza Virus via Transepithelial Dendrites of Dendritic Cells in Nasal Mucosa. Journal of Virology 89:11, pages 5904-5918.
Crossref
Crossref
Hartinio N. Nahampun, Brad Bosworth, Joan Cunnick, Mark Mogler & Kan Wang. (2015) Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice. Plant Cell Reports 34:6, pages 969-980.
Crossref
Crossref
Tao Qin, Yinyan Yin, Lulu Huang, Qinghua Yu & Qian Yang. (2015) H9N2 Influenza Whole Inactivated Virus Combined with Polyethyleneimine Strongly Enhances Mucosal and Systemic Immunity after Intranasal Immunization in Mice. Clinical and Vaccine Immunology 22:4, pages 421-429.
Crossref
Crossref
Tao Qin, Yinyan Yin, Xiaoqing Wang, Haofei Liu, Jian Lin, Qinghua Yu & Qian Yang. (2015) Whole inactivated avian Influenza H9N2 viruses induce nasal submucosal dendritic cells to sample luminal viruses via transepithelial dendrites and trigger subsequent DC maturation. Vaccine 33:11, pages 1382-1392.
Crossref
Crossref
Jason M. Neal-McKinney, Derrick R. Samuelson, Tyson P. Eucker, Mark S. Nissen, Rocio Crespo & Michael E. Konkel. (2014) Reducing Campylobacter jejuni Colonization of Poultry via Vaccination. PLoS ONE 9:12, pages e114254.
Crossref
Crossref
Maria Victoria Sanchez, Thomas Ebensen, Kai Schulze, Diego Cargnelutti, Paulina Blazejewska, Eduardo A. Scodeller & Carlos A. Guzmán. (2014) Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge. PLoS ONE 9:8, pages e104824.
Crossref
Crossref
Ayman M. Gebril, Dimitrios A. Lamprou, Manal M. Alsaadi, William H. Stimson, Alexander B. Mullen & Valerie A. Ferro. (2014) Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 10:5, pages e971-e979.
Crossref
Crossref
Kejian Yang & Steven M Varga. (2014) Mucosal vaccines against respiratory syncytial virus. Current Opinion in Virology 6, pages 78-84.
Crossref
Crossref
Judith M. Fontana, Paul J. Christos, Zuleika Michelini, Donatella Negri, Andrea Cara & Mirella Salvatore. (2014) Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice. PLoS ONE 9:5, pages e97270.
Crossref
Crossref
Pierre-Olivier Lang. (2013) Why Influenza Viruses Continue to Pose a Significant Threat to Aging and Aged Populations Worldwide. Current Geriatrics Reports 3:1, pages 56-65.
Crossref
Crossref
Beom-Jin LeePål JohansenThomas M Kündig. 2013. Therapeutic Delivery Methods: A Concise Overview of Emerging Areas. Therapeutic Delivery Methods: A Concise Overview of Emerging Areas
146
157
.
Fang He, Subaschandrabose Rajesh Kumar, Syed Musthaq Syed Khader, Yunrui Tan, Mookkan Prabakaran & Jimmy Kwang. (2013) Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus. Antiviral Research 100:1, pages 207-214.
Crossref
Crossref
Marian Wiegand, Gianni Gori-Savellini, Barbara Martorelli, Sascha Bossow, Wolfgang J. Neubert & Maria Grazia Cusi. (2013) Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector. Vaccine 31:37, pages 3888-3893.
Crossref
Crossref
Young‐Woock Noh, Ji Hyun Hong, Sang‐Mu Shim, Hye Sun Park, Hee Ho Bae, Eun Kyoung Ryu, Jung Hwan Hwang, Chul‐Ho Lee, Seong Hun Cho, Moon‐Hee Sung, Haryoung Poo & Yong Taik Lim. (2013) Polymer Nanomicelles for Efficient Mucus Delivery and Antigen‐Specific High Mucosal Immunity. Angewandte Chemie International Edition 52:30, pages 7684-7689.
Crossref
Crossref
Young‐Woock Noh, Ji Hyun Hong, Sang‐Mu Shim, Hye Sun Park, Hee Ho Bae, Eun Kyoung Ryu, Jung Hwan Hwang, Chul‐Ho Lee, Seong Hun Cho, Moon‐Hee Sung, Haryoung Poo & Yong Taik Lim. (2013) Polymer Nanomicelles for Efficient Mucus Delivery and Antigen‐Specific High Mucosal Immunity. Angewandte Chemie 125:30, pages 7838-7843.
Crossref
Crossref
Takashi KobayashiKenji FukushimaTakanori SannanNoriko SaitoYasuyuki TakiguchiYuko SatoHideki HasegawaKoichi Ishikawa. (2013) Evaluation of the Effectiveness and Safety of Chitosan Derivatives as Adjuvants for Intranasal Vaccines. Viral Immunology 26:2, pages 133-142.
Crossref
Crossref
Hana Kammoun, Xavier Roux, Dominique Raze, Anne-Sophie Debrie, Marina De Filette, Tine Ysenbaert, Nathalie Mielcarek, Xavier Saelens, Walter Fiers & Camille Locht. (2013) Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e. PLoS ONE 8:3, pages e59198.
Crossref
Crossref
M.A. Rose, J. Stoermann, J. Bittner-Brewe, M. Rosewich, O. Eickmeier & J. Schulze. (2013) Effectiveness, tolerability and patient satisfaction of paediatric live-attenuated influenza immunization (LAIV) in routine-care in Germany: A case-control-study. Trials in Vaccinology 2, pages 49-52.
Crossref
Crossref
Nikolai Petrovsky, Yoshikazu Honda-Okubo, Michael Royals, Kylie Bragg & Dimitar Sajkov. (2013) A randomized controlled study to assess the immunogenicity and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a disposable syringe jet injector device versus a traditional pre-filled syringe and needle. Trials in Vaccinology 2, pages 39-44.
Crossref
Crossref